Fluence's story has shifted from massive demand to execution risk. Its first hyperscaler MSA finally converted into an $850M order, but production delays, quality issues and reduced guidance raised doubts about whether it can deliver. The stock lost its trend and broke every major support, a sign the market saw the change before anyone could explain it. x.comÂ